| 1 |
34622970 | Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites. | 2022 Feb |
1 |
| 2 |
34797531 | Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial. | 2022 Feb |
1 |
| 3 |
35096395 | Diffuse large B-cell lymphoma with uncommon cardiac invasion. | 2022 |
1 |
| 4 |
35297262 | Colonic infiltration of chronic lymphocytic leukemia with Hodgkin Reed Sternberg-like cells. | 2022 Mar 17 |
1 |
| 5 |
35317846 | RNA-Seq analysis of gene expression in 25 cases of canine lymphoma undergoing CHOP chemotherapy. | 2022 Mar 22 |
1 |
| 6 |
35573753 | COVID-19-Associated Pneumonia in a B-Cell-Depleted Patient With Non-Hodgkin Lymphoma: Recovery With Hyperimmune Plasma. | 2022 Apr |
1 |
| 7 |
33483276 | Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCL. | 2021 Mar |
2 |
| 8 |
34124276 | Suppression of DLBCL Progression by the E3 Ligase Trim35 Is Mediated by CLOCK Degradation and NK Cell Infiltration. | 2021 |
1 |
| 9 |
34586105 | Tafasitamab for refractory/relapsed diffuse large B-cell lymphoma. | 2021 Sep |
1 |
| 10 |
34732441 | Clinicopathologic and Prognostic Significance of Bruton's Tyrosine Kinase Expression in Diffuse Large B-Cell Lymphoma. | 2021 Nov |
2 |
| 11 |
34745610 | Intratumoral T-cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B-cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R-CHOP) chemoimmunotherapy. | 2021 |
2 |
| 12 |
34765356 | Vincristine-Induced Bilateral Vocal Cord Palsy in an Adult Male With Diffuse Large B-Cell Lymphoma. | 2021 Oct |
1 |
| 13 |
34895738 | Complete response in a frail patient with high-grade B-cell lymphoma to only one cycle of R-CHOP or to prolonged COVID-19? | 2021 Aug-Dec |
1 |
| 14 |
34990525 | Pegfilgrastim Prophylaxis is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study. | 2021 Dec 30 |
1 |
| 15 |
31902733 | Primary Dural Diffuse Large B-cell Lymphoma: A Comprehensive Review of Survival and Treatment Outcomes. | 2020 Feb |
1 |
| 16 |
32187361 | Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. | 2020 May 14 |
1 |
| 17 |
32417940 | Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life. | 2020 Jul |
1 |
| 18 |
32648457 | Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center. | 2020 Jul |
1 |
| 19 |
32915975 | Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma. | 2020 Sep 22 |
1 |
| 20 |
33093947 | ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial. | 2020 |
1 |
| 21 |
33230132 | Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas. | 2020 Nov 23 |
1 |
| 22 |
33317571 | New agents and regimens for diffuse large B cell lymphoma. | 2020 Dec 14 |
1 |
| 23 |
30674940 | Expression of NOTCH3 exon 16 differentiates Diffuse Large B-cell Lymphoma into molecular subtypes and is associated with prognosis. | 2019 Jan 23 |
1 |
| 24 |
30967394 | MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma. | 2019 Apr 9 |
1 |
| 25 |
31118164 | R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma. | 2019 Jul 18 |
1 |
| 26 |
31222719 | Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity. | 2019 Oct |
1 |
| 27 |
31280230 | Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan. | 2019 Jul-Aug |
1 |
| 28 |
31314918 | Similar effectiveness of R-CHOP-14 and -21 in diffuse large B-cell lymphoma-data from the prospective German Tumour Registry Lymphatic Neoplasms. | 2019 Nov |
1 |
| 29 |
31801186 | Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma. | 2019 Nov 30 |
2 |
| 30 |
29380942 | Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas. | 2018 Sep |
1 |
| 31 |
29963517 | Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent. | 2018 Jun |
1 |
| 32 |
30101910 | The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma. | 2018 Dec 15 |
1 |
| 33 |
30172345 | Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study. | 2018 Sep |
1 |
| 34 |
30313105 | Intravascular large B-cell lymphoma presenting as multiple stroke: A case report. | 2018 Oct |
1 |
| 35 |
30788202 | Primary Vaginal Non-Hodgkin Lymphoma. | 2018 Dec 11 |
1 |
| 36 |
26449182 | CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin. | 2017 Jun |
1 |
| 37 |
28559645 | Comorbidity between HTLV-1-associated adult T-cell lymphoma/leukemia and verrucous carcinoma: a case report. | 2017 Mar 30 |
1 |
| 38 |
28791403 | Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas. | 2017 Oct |
1 |
| 39 |
28978846 | Molecular pathogenesis and treatment strategy in diffuse large B-cell lymphoma. | 2017 |
1 |
| 40 |
24675549 | Is R-CHOP Therapy a Lymphoma Growth Factor? | 2016 Jan-Feb |
1 |
| 41 |
26435364 | Influence of dose reduction of vincristine in R-CHOP on outcomes of diffuse large B cell lymphoma. | 2016 Jan |
1 |
| 42 |
27188649 | Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients. | 2016 |
2 |
| 43 |
27382104 | Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736. | 2016 Sep 1 |
1 |
| 44 |
28030899 | Analysis of treatment outcomes for primary tonsillar lymphoma. | 2016 Dec |
1 |
| 45 |
25430047 | Prognostic impact of the TP53 rs1625895 polymorphism in DLBCL patients. | 2015 Apr |
1 |
| 46 |
25666327 | Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: A case report and literature review. | 2015 Sep-Oct |
1 |
| 47 |
25675909 | Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma. | 2015 Jun 1 |
1 |
| 48 |
26334344 | Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group. | 2015 |
1 |
| 49 |
26458444 | [Diffuse large B-cell lymphoma: therapeutic development based on clinical and biological heterogeneity]. | 2015 Oct |
1 |
| 50 |
24493716 | Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. | 2014 Apr 10 |
1 |